Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nhlh1
|
ENSMUSG00000051251.3 | nescient helix loop helix 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_172053299_172054699 | Nhlh1 | 3574 | 0.139239 | 0.84 | 3.2e-17 | Click! |
chr1_172056022_172057415 | Nhlh1 | 855 | 0.450809 | 0.57 | 2.4e-06 | Click! |
chr1_172052840_172053217 | Nhlh1 | 4545 | 0.127589 | 0.53 | 1.5e-05 | Click! |
chr1_172049288_172049766 | Nhlh1 | 8046 | 0.114260 | 0.41 | 1.2e-03 | Click! |
chr1_172055378_172055530 | Nhlh1 | 2119 | 0.191766 | 0.41 | 1.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_12947702_12949640 | 16.43 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr14_118924325_118925724 | 15.61 |
Dzip1 |
DAZ interacting protein 1 |
363 |
0.85 |
chr4_125490136_125491914 | 12.50 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr15_71727651_71728452 | 12.45 |
Fam135b |
family with sequence similarity 135, member B |
213 |
0.95 |
chrX_98149736_98151206 | 12.04 |
Ar |
androgen receptor |
1702 |
0.52 |
chr5_117841452_117842996 | 11.58 |
Nos1 |
nitric oxide synthase 1, neuronal |
38 |
0.98 |
chr15_103503210_103504096 | 11.24 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
376 |
0.81 |
chr5_138610043_138610442 | 11.08 |
Gm15497 |
predicted gene 15497 |
497 |
0.66 |
chr16_60605121_60606481 | 11.03 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr2_21367263_21369086 | 10.84 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr10_81024569_81025640 | 10.82 |
Gm16099 |
predicted gene 16099 |
21 |
0.8 |
chr14_122478089_122479067 | 10.67 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr12_17175425_17176882 | 10.63 |
Kcnf1 |
potassium voltage-gated channel, subfamily F, member 1 |
735 |
0.7 |
chr3_8509825_8511666 | 10.56 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr4_153481347_153482221 | 10.53 |
Ajap1 |
adherens junction associated protein 1 |
395 |
0.92 |
chr6_55676662_55677830 | 10.45 |
Neurod6 |
neurogenic differentiation 6 |
4017 |
0.26 |
chr8_45507516_45508498 | 10.32 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr6_104492794_104494036 | 10.22 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr5_37162832_37163752 | 10.06 |
Gm1043 |
predicted gene 1043 |
443 |
0.83 |
chr16_78930672_78931913 | 9.99 |
Chodl |
chondrolectin |
15 |
0.98 |
chr1_74855603_74856370 | 9.97 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
1052 |
0.36 |
chr14_124191809_124193012 | 9.77 |
Fgf14 |
fibroblast growth factor 14 |
492 |
0.88 |
chr9_91363965_91365514 | 9.75 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr15_76519928_76521866 | 9.70 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr1_129273098_129274282 | 9.38 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
205 |
0.95 |
chr10_41070697_41071486 | 9.34 |
Gpr6 |
G protein-coupled receptor 6 |
1194 |
0.41 |
chr1_84695175_84696294 | 9.33 |
Mir5126 |
microRNA 5126 |
105 |
0.73 |
chr10_69705909_69707430 | 9.32 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr8_125897868_125898882 | 9.30 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chr7_98193340_98194780 | 9.23 |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) |
5421 |
0.16 |
chr17_35702700_35702891 | 9.12 |
Ddr1 |
discoidin domain receptor family, member 1 |
478 |
0.54 |
chr10_73096427_73097649 | 9.11 |
Pcdh15 |
protocadherin 15 |
2304 |
0.33 |
chr12_87026152_87027307 | 8.93 |
Tmem63c |
transmembrane protein 63c |
113 |
0.95 |
chr11_28583104_28584333 | 8.92 |
Ccdc85a |
coiled-coil domain containing 85A |
277 |
0.94 |
chr7_126823319_126824529 | 8.89 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr9_75610451_75611426 | 8.80 |
Tmod2 |
tropomodulin 2 |
137 |
0.94 |
chr11_116920303_116921024 | 8.80 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
1800 |
0.3 |
chrX_96712746_96713886 | 8.64 |
Gpr165 |
G protein-coupled receptor 165 |
125 |
0.98 |
chr8_31089411_31091663 | 8.63 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr2_25877424_25878675 | 8.61 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr7_4119233_4120703 | 8.57 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr6_138420211_138420823 | 8.57 |
Lmo3 |
LIM domain only 3 |
935 |
0.55 |
chr1_177446374_177448525 | 8.48 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr5_131306365_131308106 | 8.48 |
Galnt17 |
polypeptide N-acetylgalactosaminyltransferase 17 |
320 |
0.93 |
chr19_47019038_47019748 | 8.46 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
4240 |
0.14 |
chr10_87492356_87492935 | 8.45 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
1015 |
0.55 |
chr5_108549212_108550612 | 8.45 |
Cplx1 |
complexin 1 |
88 |
0.95 |
chr11_115366861_115367995 | 8.44 |
Hid1 |
HID1 domain containing |
181 |
0.88 |
chr12_118848802_118850409 | 8.32 |
Sp8 |
trans-acting transcription factor 8 |
2019 |
0.36 |
chr7_82869041_82870364 | 8.28 |
Mex3b |
mex3 RNA binding family member B |
2369 |
0.22 |
chr5_34286939_34287692 | 8.22 |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
1011 |
0.34 |
chr4_155344717_155346023 | 8.21 |
Prkcz |
protein kinase C, zeta |
12 |
0.96 |
chr2_181155937_181157234 | 8.18 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr3_94363290_94364465 | 8.13 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1374 |
0.19 |
chr5_125532320_125533519 | 8.12 |
Tmem132b |
transmembrane protein 132B |
532 |
0.76 |
chr14_68123421_68125146 | 8.00 |
Nefm |
neurofilament, medium polypeptide |
563 |
0.74 |
chr3_158560953_158561855 | 7.97 |
Lrrc7 |
leucine rich repeat containing 7 |
59 |
0.99 |
chr3_17793835_17795104 | 7.93 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr6_54564534_54565307 | 7.93 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr9_8900980_8902109 | 7.85 |
Pgr |
progesterone receptor |
1076 |
0.65 |
chr13_34125172_34126139 | 7.81 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chrX_105390628_105392456 | 7.79 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr12_86989498_86990698 | 7.75 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
332 |
0.85 |
chr15_98954680_98955277 | 7.70 |
Tuba1a |
tubulin, alpha 1A |
1275 |
0.2 |
chr5_90758918_90760166 | 7.69 |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
164 |
0.91 |
chr15_74563319_74564610 | 7.68 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr5_27262523_27263109 | 7.63 |
Dpp6 |
dipeptidylpeptidase 6 |
841 |
0.69 |
chr6_112488978_112490218 | 7.61 |
Oxtr |
oxytocin receptor |
345 |
0.86 |
chr18_43686487_43688415 | 7.57 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr13_55484574_55485692 | 7.56 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr1_42697532_42698715 | 7.56 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr10_79612978_79614016 | 7.55 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
503 |
0.62 |
chr1_132541040_132543287 | 7.55 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr18_25755266_25755518 | 7.55 |
Celf4 |
CUGBP, Elav-like family member 4 |
1235 |
0.54 |
chr14_96517868_96518996 | 7.54 |
Klhl1 |
kelch-like 1 |
670 |
0.78 |
chr7_4120918_4121688 | 7.52 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
575 |
0.45 |
chr7_105425216_105426515 | 7.49 |
Cckbr |
cholecystokinin B receptor |
48 |
0.95 |
chr13_51566607_51568077 | 7.41 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
258 |
0.94 |
chr8_121730928_121732115 | 7.34 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr9_21196536_21198489 | 7.32 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr2_162660089_162661112 | 7.31 |
Ptprt |
protein tyrosine phosphatase, receptor type, T |
494 |
0.5 |
chr11_81152519_81153660 | 7.30 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
232 |
0.96 |
chr7_121391567_121393161 | 7.29 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr6_90781027_90782541 | 7.29 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr6_119328752_119331284 | 7.29 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr8_14381737_14382325 | 7.28 |
Dlgap2 |
DLG associated protein 2 |
35 |
0.98 |
chr7_16982884_16983633 | 7.26 |
Gm42372 |
predicted gene, 42372 |
172 |
0.9 |
chr11_112784278_112785462 | 7.25 |
Sox9 |
SRY (sex determining region Y)-box 9 |
2646 |
0.24 |
chr6_82401650_82403284 | 7.22 |
Tacr1 |
tachykinin receptor 1 |
8 |
0.99 |
chr6_56361313_56362588 | 7.20 |
Pde1c |
phosphodiesterase 1C |
95 |
0.98 |
chr13_60175871_60177453 | 7.16 |
Gm48488 |
predicted gene, 48488 |
20 |
0.8 |
chr15_76124987_76126454 | 7.09 |
BC024139 |
cDNA sequence BC024139 |
351 |
0.73 |
chr10_29146671_29147722 | 7.06 |
Soga3 |
SOGA family member 3 |
139 |
0.95 |
chr7_75308076_75309218 | 7.00 |
1500012K07Rik |
RIKEN cDNA 1500012K07 gene |
49 |
0.78 |
chr14_123626367_123627548 | 6.99 |
Nalcn |
sodium leak channel, non-selective |
4 |
0.98 |
chrX_103185752_103186844 | 6.95 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
342 |
0.83 |
chr9_52678302_52679671 | 6.94 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chr2_37517668_37518398 | 6.93 |
Gpr21 |
G protein-coupled receptor 21 |
1407 |
0.29 |
chrX_5467696_5468887 | 6.92 |
Mycs |
myc-like oncogene, s-myc protein |
974 |
0.62 |
chr13_96131908_96133176 | 6.92 |
Sv2c |
synaptic vesicle glycoprotein 2c |
35 |
0.94 |
chr9_52148115_52149635 | 6.88 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr2_29747113_29747729 | 6.87 |
Gm13420 |
predicted gene 13420 |
4264 |
0.13 |
chrX_110817183_110817473 | 6.86 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
3048 |
0.3 |
chr4_101508533_101509308 | 6.81 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
890 |
0.64 |
chr2_172040251_172043672 | 6.79 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr2_118779656_118780774 | 6.76 |
Disp2 |
dispatched RND tramsporter family member 2 |
456 |
0.71 |
chr10_119692249_119692864 | 6.75 |
Grip1 |
glutamate receptor interacting protein 1 |
502 |
0.82 |
chr7_40898734_40899964 | 6.70 |
Vstm2b |
V-set and transmembrane domain containing 2B |
17 |
0.93 |
chr9_52678043_52678278 | 6.67 |
AI593442 |
expressed sequence AI593442 |
1269 |
0.41 |
chr2_165563067_165564027 | 6.64 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
31485 |
0.13 |
chr7_99270744_99271357 | 6.63 |
Map6 |
microtubule-associated protein 6 |
1918 |
0.23 |
chr11_54305749_54306148 | 6.59 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
1746 |
0.28 |
chr1_158362036_158363261 | 6.58 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr15_20448699_20449797 | 6.54 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chr1_135248312_135249161 | 6.50 |
Gm26642 |
predicted gene, 26642 |
175 |
0.91 |
chr10_3863416_3864702 | 6.50 |
Gm16149 |
predicted gene 16149 |
5548 |
0.21 |
chr19_59074782_59076053 | 6.49 |
Shtn1 |
shootin 1 |
652 |
0.71 |
chr4_87229430_87230722 | 6.48 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
346 |
0.93 |
chr5_113309676_113310735 | 6.47 |
Sgsm1 |
small G protein signaling modulator 1 |
492 |
0.7 |
chr18_62324201_62324630 | 6.47 |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
211 |
0.96 |
chr13_69737356_69737994 | 6.45 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
2214 |
0.21 |
chr10_84757399_84758243 | 6.45 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1759 |
0.41 |
chr7_141949754_141950818 | 6.43 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr2_25176826_25179102 | 6.43 |
Nrarp |
Notch-regulated ankyrin repeat protein |
2794 |
0.09 |
chr7_57509014_57510202 | 6.43 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
237 |
0.95 |
chr17_15371644_15373099 | 6.40 |
Dll1 |
delta like canonical Notch ligand 1 |
540 |
0.73 |
chr18_43391758_43391959 | 6.40 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1519 |
0.46 |
chr13_83720833_83721451 | 6.38 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
239 |
0.89 |
chr4_36950134_36952137 | 6.38 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
88 |
0.97 |
chr4_91374442_91375761 | 6.38 |
Elavl2 |
ELAV like RNA binding protein 1 |
1206 |
0.41 |
chr9_54764594_54766122 | 6.37 |
Crabp1 |
cellular retinoic acid binding protein I |
610 |
0.69 |
chr4_140245362_140247262 | 6.36 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr2_113828248_113829427 | 6.36 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr9_75683375_75684591 | 6.35 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr9_103112101_103112762 | 6.34 |
Rab6b |
RAB6B, member RAS oncogene family |
624 |
0.68 |
chr5_103209022_103210413 | 6.31 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr11_119546026_119546256 | 6.29 |
Nptx1 |
neuronal pentraxin 1 |
1612 |
0.29 |
chr13_58809397_58810364 | 6.28 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr13_78194785_78195954 | 6.20 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1004 |
0.42 |
chr2_129038448_129039729 | 6.20 |
Vinac1 |
vinculin/alpha-catenin family member 1 |
9084 |
0.11 |
chr13_10359785_10361166 | 6.20 |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
88 |
0.97 |
chr6_114282516_114283979 | 6.17 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr2_181766837_181767244 | 6.17 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr7_119184137_119185474 | 6.14 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chr19_5695606_5696740 | 6.13 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
3278 |
0.08 |
chr2_178141581_178143125 | 6.09 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr4_129226645_129228191 | 6.08 |
C77080 |
expressed sequence C77080 |
62 |
0.96 |
chr7_79505833_79506958 | 6.07 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr2_151966993_151968089 | 6.05 |
Mir1953 |
microRNA 1953 |
76 |
0.96 |
chr11_61453075_61454398 | 6.00 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr9_41377643_41378358 | 5.99 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chr11_78694313_78696159 | 5.94 |
Nlk |
nemo like kinase |
1258 |
0.39 |
chr6_101198088_101199306 | 5.93 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr8_62951127_62952454 | 5.93 |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
10 |
0.98 |
chr1_87155269_87156464 | 5.93 |
Ecel1 |
endothelin converting enzyme-like 1 |
299 |
0.8 |
chr14_64591036_64591686 | 5.92 |
Mir3078 |
microRNA 3078 |
176 |
0.84 |
chr9_20745303_20746611 | 5.92 |
Olfm2 |
olfactomedin 2 |
392 |
0.82 |
chr8_40633961_40635062 | 5.91 |
Mtmr7 |
myotubularin related protein 7 |
248 |
0.92 |
chr8_121649714_121650258 | 5.91 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
2915 |
0.16 |
chr6_126739477_126740745 | 5.90 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
40 |
0.97 |
chr1_34677886_34678995 | 5.89 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
252 |
0.89 |
chr2_158611997_158612747 | 5.88 |
Gm14205 |
predicted gene 14205 |
552 |
0.57 |
chr5_97935061_97936082 | 5.88 |
Antxr2 |
anthrax toxin receptor 2 |
60524 |
0.11 |
chr9_69758963_69761490 | 5.88 |
Foxb1 |
forkhead box B1 |
714 |
0.5 |
chr5_27841594_27842778 | 5.85 |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A |
37 |
0.97 |
chr5_38318977_38320095 | 5.85 |
Drd5 |
dopamine receptor D5 |
169 |
0.91 |
chr7_140080531_140082545 | 5.84 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr10_26695189_26696089 | 5.84 |
Gm48893 |
predicted gene, 48893 |
65 |
0.97 |
chr19_47014128_47015152 | 5.83 |
Ina |
internexin neuronal intermediate filament protein, alpha |
58 |
0.88 |
chr9_110051810_110053856 | 5.81 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr1_42703141_42704653 | 5.81 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr12_117688775_117690161 | 5.79 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr4_45825879_45827166 | 5.79 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
401 |
0.81 |
chr5_37821115_37822599 | 5.78 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr11_106019908_106020882 | 5.77 |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
6622 |
0.1 |
chr5_34287784_34288352 | 5.76 |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
258 |
0.7 |
chr8_14382368_14383445 | 5.75 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr12_58212274_58214477 | 5.73 |
Sstr1 |
somatostatin receptor 1 |
1571 |
0.52 |
chrX_110814269_110815716 | 5.73 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
712 |
0.71 |
chr5_120710211_120711265 | 5.70 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chr5_135806693_135807939 | 5.65 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chr6_91843070_91844089 | 5.64 |
Grip2 |
glutamate receptor interacting protein 2 |
16329 |
0.15 |
chr5_37028040_37029531 | 5.63 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
327 |
0.87 |
chr4_91399504_91400258 | 5.63 |
Elavl2 |
ELAV like RNA binding protein 1 |
95 |
0.97 |
chr15_78717021_78717410 | 5.61 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
898 |
0.51 |
chr8_80610461_80611656 | 5.59 |
Frem3 |
Fras1 related extracellular matrix protein 3 |
22 |
0.98 |
chrX_82814349_82815696 | 5.58 |
Gm14741 |
predicted gene 14741 |
56584 |
0.15 |
chr14_6286765_6287923 | 5.58 |
Gm3411 |
predicted gene 3411 |
94 |
0.95 |
chr18_72350573_72351222 | 5.57 |
Dcc |
deleted in colorectal carcinoma |
120 |
0.98 |
chr6_118196646_118197798 | 5.55 |
Ret |
ret proto-oncogene |
89 |
0.97 |
chrX_86191680_86192868 | 5.52 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr4_91400388_91400985 | 5.52 |
Elavl2 |
ELAV like RNA binding protein 1 |
99 |
0.97 |
chr17_68840909_68842079 | 5.52 |
Gm49949 |
predicted gene, 49949 |
2531 |
0.25 |
chr7_51624664_51625766 | 5.51 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
67 |
0.98 |
chr2_25318080_25319601 | 5.50 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr8_46208542_46209617 | 5.50 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
1951 |
0.2 |
chr3_102011198_102013204 | 5.49 |
Nhlh2 |
nescient helix loop helix 2 |
2046 |
0.32 |
chr8_12398370_12398923 | 5.49 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr7_16810738_16811990 | 5.49 |
Fkrp |
fukutin related protein |
4157 |
0.12 |
chr7_109493000_109494039 | 5.49 |
Trim66 |
tripartite motif-containing 66 |
219 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.7 | 22.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
5.1 | 10.2 | GO:0048880 | sensory system development(GO:0048880) |
5.1 | 15.2 | GO:0021586 | pons maturation(GO:0021586) |
4.6 | 13.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
4.4 | 4.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
4.3 | 34.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
4.1 | 12.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.1 | 12.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
4.1 | 12.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.1 | 8.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
4.0 | 12.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.8 | 11.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
3.7 | 11.2 | GO:0021550 | medulla oblongata development(GO:0021550) |
3.7 | 22.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.7 | 11.1 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.7 | 11.1 | GO:0001757 | somite specification(GO:0001757) |
3.7 | 14.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
3.7 | 7.3 | GO:0072034 | renal vesicle induction(GO:0072034) |
3.6 | 10.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.5 | 14.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
3.3 | 9.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.3 | 16.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.2 | 22.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.1 | 9.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.0 | 3.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.0 | 9.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.8 | 2.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.8 | 11.2 | GO:0035106 | operant conditioning(GO:0035106) |
2.8 | 13.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.7 | 2.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.7 | 27.0 | GO:0071625 | vocalization behavior(GO:0071625) |
2.7 | 2.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
2.6 | 7.9 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
2.6 | 7.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.6 | 5.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.6 | 10.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.6 | 5.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.6 | 30.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.5 | 7.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.5 | 7.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.5 | 12.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
2.5 | 7.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.5 | 4.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.4 | 4.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.3 | 6.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.3 | 2.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.2 | 9.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.2 | 60.9 | GO:0001964 | startle response(GO:0001964) |
2.2 | 10.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
2.1 | 8.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.1 | 8.5 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
2.1 | 6.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.1 | 4.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.1 | 2.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.0 | 4.0 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
2.0 | 6.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.0 | 6.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.0 | 11.9 | GO:0048840 | otolith development(GO:0048840) |
2.0 | 5.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.0 | 7.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 7.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.9 | 7.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.9 | 3.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.9 | 7.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 1.8 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.8 | 3.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.8 | 1.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.8 | 1.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.8 | 7.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.8 | 7.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.8 | 5.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.8 | 1.8 | GO:0009629 | response to gravity(GO:0009629) |
1.8 | 3.6 | GO:0060174 | limb bud formation(GO:0060174) |
1.8 | 18.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.8 | 5.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.8 | 3.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.8 | 37.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.8 | 5.3 | GO:0030070 | insulin processing(GO:0030070) |
1.7 | 3.5 | GO:0060594 | mammary gland specification(GO:0060594) |
1.7 | 3.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.7 | 5.2 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.7 | 5.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.7 | 5.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.7 | 1.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.7 | 6.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.7 | 20.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.6 | 13.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 6.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.6 | 4.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.6 | 4.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.6 | 86.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.6 | 3.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
1.6 | 3.2 | GO:0046959 | habituation(GO:0046959) |
1.6 | 19.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.6 | 4.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.6 | 6.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 6.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.5 | 4.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.5 | 6.1 | GO:0050955 | thermoception(GO:0050955) |
1.5 | 4.6 | GO:0097264 | self proteolysis(GO:0097264) |
1.5 | 6.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.5 | 1.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.5 | 8.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.5 | 5.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.5 | 2.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.5 | 4.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.5 | 4.4 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 1.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.4 | 4.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.4 | 1.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.4 | 2.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.4 | 2.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.4 | 10.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.4 | 2.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 1.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.4 | 4.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 4.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 5.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.4 | 2.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 9.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.4 | 2.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.4 | 8.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.4 | 4.1 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.4 | 5.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.4 | 4.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.3 | 1.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.3 | 22.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.3 | 2.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.3 | 4.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.3 | 4.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.3 | 5.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.3 | 5.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.3 | 2.5 | GO:0032898 | neurotrophin production(GO:0032898) |
1.3 | 2.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 5.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.3 | 10.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.3 | 2.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 5.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 2.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.2 | 2.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.2 | 2.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.2 | 3.7 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.2 | 3.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.2 | 1.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
1.2 | 3.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.2 | 7.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.2 | 14.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 6.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.2 | 3.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.2 | 2.4 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
1.2 | 4.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.2 | 4.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.2 | 4.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.2 | 3.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.2 | 1.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 3.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 | 34.8 | GO:0019228 | neuronal action potential(GO:0019228) |
1.2 | 3.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.1 | 3.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.1 | 2.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 6.8 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.1 | 3.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 6.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.1 | 5.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.1 | 2.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 4.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.1 | 1.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.1 | 1.1 | GO:0030432 | peristalsis(GO:0030432) |
1.1 | 7.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
1.0 | 3.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.0 | 4.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 5.2 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 8.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.0 | 2.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.0 | 5.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.0 | 1.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.0 | 4.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.0 | 3.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.0 | 1.0 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 2.0 | GO:0031223 | auditory behavior(GO:0031223) |
1.0 | 4.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 2.0 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.0 | 2.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.0 | 2.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.0 | 16.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 3.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.0 | 3.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.0 | 6.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.0 | 1.0 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.0 | 2.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 8.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 23.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
1.0 | 4.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.0 | 9.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 2.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 2.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.0 | 1.9 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.0 | 4.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.9 | 2.8 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.9 | 8.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.9 | 2.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.9 | 2.8 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 0.9 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.9 | 5.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.9 | 6.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.9 | 5.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.9 | 0.9 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.9 | 1.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.9 | 0.9 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
0.9 | 2.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.9 | 3.6 | GO:0008038 | neuron recognition(GO:0008038) |
0.9 | 0.9 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.9 | 56.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 3.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.9 | 1.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.9 | 3.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 7.0 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.9 | 2.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.9 | 2.6 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.9 | 1.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.9 | 1.7 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.8 | 1.7 | GO:0060157 | urinary bladder development(GO:0060157) |
0.8 | 2.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.8 | 0.8 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.8 | 4.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 5.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.8 | 2.5 | GO:0035789 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.8 | 2.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.8 | 4.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.8 | 4.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 2.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.8 | 3.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 1.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 2.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 2.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.8 | 2.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 6.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.8 | 2.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 2.3 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 2.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.8 | 3.9 | GO:0014028 | notochord formation(GO:0014028) |
0.8 | 2.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.8 | 0.8 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.8 | 1.6 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.8 | 0.8 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.8 | 3.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.8 | 2.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 2.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.8 | 3.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.8 | 5.3 | GO:0060384 | innervation(GO:0060384) |
0.8 | 3.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.7 | 1.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 4.5 | GO:0007614 | short-term memory(GO:0007614) |
0.7 | 2.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 3.0 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.7 | 2.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.7 | 2.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 2.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.7 | 2.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 1.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 7.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 2.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.7 | 2.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.7 | 2.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.7 | 2.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.7 | 1.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.7 | 4.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.7 | 2.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 2.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.7 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 2.1 | GO:1901491 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 2.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.7 | 0.7 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.7 | 2.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.7 | 3.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.7 | 2.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.7 | 1.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.7 | 5.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.7 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 1.4 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.7 | 7.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.7 | 2.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 0.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 4.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.7 | 0.7 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.7 | 3.4 | GO:0072044 | collecting duct development(GO:0072044) |
0.7 | 1.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.7 | 2.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.7 | 0.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.7 | 7.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.7 | 5.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 6.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.7 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 1.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 10.5 | GO:0007616 | long-term memory(GO:0007616) |
0.7 | 2.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 15.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.6 | 5.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.6 | 3.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.6 | 3.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 0.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.6 | 1.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.6 | 9.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 0.6 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.6 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 4.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.6 | 3.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 | 3.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.6 | 1.9 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 1.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 2.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 1.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 4.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 7.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.6 | 1.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 3.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 24.7 | GO:0007613 | memory(GO:0007613) |
0.6 | 4.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 1.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 4.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.6 | 2.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.6 | 1.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.6 | 0.6 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.6 | 11.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 2.4 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 2.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.6 | 2.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 0.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.6 | 1.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 5.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 3.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.6 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 3.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 1.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 1.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 9.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.6 | 1.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 4.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 48.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.6 | 1.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.6 | 1.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 2.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 0.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.6 | 2.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 3.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 0.6 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.6 | 0.6 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.6 | 4.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 4.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.6 | 1.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 1.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 2.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.6 | 4.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.6 | 1.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.6 | 2.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.6 | 5.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.6 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.6 | 2.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 7.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.6 | 0.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.6 | 2.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.6 | 1.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 5.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 1.7 | GO:0001975 | response to amphetamine(GO:0001975) |
0.6 | 0.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 1.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.6 | 2.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 1.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 0.5 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.5 | 3.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 1.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 1.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 2.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 1.6 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.5 | 6.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 8.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 14.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.5 | 2.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 1.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 2.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 4.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 3.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 1.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.5 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.5 | 3.6 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.5 | 2.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 0.5 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.5 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 4.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 4.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.5 | 7.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 2.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 4.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 3.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.5 | 2.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 24.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.5 | 1.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.5 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.5 | 1.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 | 5.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.5 | 1.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 0.5 | GO:0043307 | eosinophil activation(GO:0043307) |
0.5 | 1.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 3.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 0.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 2.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 11.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.5 | 2.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.5 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 4.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 1.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 4.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.5 | 0.5 | GO:0002339 | B cell selection(GO:0002339) |
0.5 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.5 | 1.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 9.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.5 | 0.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 8.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.5 | 1.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.5 | 1.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.4 | GO:0033504 | floor plate development(GO:0033504) |
0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 1.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 0.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.5 | 1.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.5 | 3.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 2.3 | GO:0048668 | collateral sprouting(GO:0048668) |
0.5 | 1.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.5 | 1.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.4 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 1.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 2.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.8 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.4 | 1.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.4 | GO:0072017 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) distal tubule development(GO:0072017) |
0.4 | 8.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.4 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.9 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 1.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.4 | 2.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 1.3 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.4 | 0.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.4 | 1.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 0.4 | GO:0002118 | aggressive behavior(GO:0002118) |
0.4 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 3.8 | GO:0098868 | bone growth(GO:0098868) |
0.4 | 0.8 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.4 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.8 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) succinate transport(GO:0015744) |
0.4 | 6.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 2.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 1.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 2.1 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 2.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 2.9 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.4 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 2.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.4 | 1.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 3.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.4 | 2.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 0.8 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.4 | 1.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.4 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 0.8 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 2.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 0.7 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.4 | 0.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 5.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 7.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.4 | 1.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 1.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 0.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.4 | 1.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.4 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 1.1 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.4 | 1.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 2.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 0.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.4 | 1.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 1.4 | GO:0060004 | reflex(GO:0060004) |
0.4 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.4 | 1.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 0.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 2.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 1.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 1.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 1.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.7 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.3 | 0.3 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.3 | 1.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 2.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 1.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 11.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 6.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.6 | GO:0021544 | subpallium development(GO:0021544) |
0.3 | 1.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.6 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.3 | 3.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.3 | 5.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 7.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 0.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 0.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.9 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 1.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 2.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 2.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 2.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.9 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 4.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 3.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 3.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 1.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 1.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 1.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.3 | 1.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.3 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 1.0 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.3 | 0.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 0.8 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 1.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.3 | 1.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 3.9 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.2 | 0.5 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.2 | 0.5 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.5 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.2 | 1.0 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.2 | 6.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 2.4 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 1.4 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 2.0 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.2 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 4.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 1.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.2 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 0.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 3.7 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 2.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.5 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.2 | 0.6 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 4.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 3.6 | GO:0008306 | associative learning(GO:0008306) |
0.2 | 1.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 2.1 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 1.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 2.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 2.0 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 3.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.6 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 5.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 6.1 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 1.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 1.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.2 | 1.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 1.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 4.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.2 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.4 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.7 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 2.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 1.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.5 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 3.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 0.2 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.3 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 1.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 3.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 1.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.9 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.7 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.3 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.1 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0033026 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 3.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 3.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.5 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.3 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.2 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.7 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 2.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 2.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0051036 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0071639 | regulation of interleukin-18 production(GO:0032661) positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.1 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.2 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.4 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 1.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 3.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.2 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 3.9 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.9 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 1.7 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.0 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0021782 | glial cell development(GO:0021782) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 29.5 | GO:0005883 | neurofilament(GO:0005883) |
3.3 | 3.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
3.1 | 9.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.0 | 8.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.8 | 34.2 | GO:0043194 | axon initial segment(GO:0043194) |
2.7 | 26.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.6 | 18.4 | GO:0032584 | growth cone membrane(GO:0032584) |
2.5 | 10.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.4 | 7.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.4 | 69.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.2 | 8.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 25.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.1 | 6.3 | GO:0072534 | perineuronal net(GO:0072534) |
2.1 | 10.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.0 | 6.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.0 | 2.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 36.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.9 | 1.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.7 | 3.5 | GO:0097433 | dense body(GO:0097433) |
1.7 | 5.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.6 | 48.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.5 | 6.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.5 | 9.1 | GO:0043203 | axon hillock(GO:0043203) |
1.5 | 4.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.5 | 13.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.5 | 1.5 | GO:0044304 | main axon(GO:0044304) |
1.4 | 1.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 32.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 8.1 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 2.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.3 | 19.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.3 | 35.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.3 | 10.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 17.4 | GO:0031045 | dense core granule(GO:0031045) |
1.2 | 4.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.1 | 9.0 | GO:0071437 | invadopodium(GO:0071437) |
1.1 | 10.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 6.7 | GO:0016342 | catenin complex(GO:0016342) |
1.1 | 5.5 | GO:0033268 | node of Ranvier(GO:0033268) |
1.1 | 4.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.1 | 54.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.1 | 39.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 8.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 2.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.0 | 10.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.0 | 8.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.9 | 7.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 130.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.9 | 3.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 3.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 7.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 2.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 30.8 | GO:0030315 | T-tubule(GO:0030315) |
0.8 | 5.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.8 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 3.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 7.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 2.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 7.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 3.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 1.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 2.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.7 | 55.4 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 1.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.7 | 3.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 4.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 7.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 0.6 | GO:0044393 | microspike(GO:0044393) |
0.6 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 7.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.8 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 10.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.6 | 1.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.2 | GO:0005818 | aster(GO:0005818) |
0.5 | 1.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 1.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 5.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 19.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.5 | 41.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 2.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 0.5 | GO:0044298 | cell body membrane(GO:0044298) |
0.5 | 33.2 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 28.8 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 5.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 1.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 3.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 2.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 3.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 47.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 1.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 2.5 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 1.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 10.5 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 94.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 7.6 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 43.8 | GO:0045202 | synapse(GO:0045202) |
0.3 | 1.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 2.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 2.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 73.3 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.3 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 2.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 2.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 6.6 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 24.0 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 0.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 2.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 3.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 6.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 4.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 2.8 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 2.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.4 | 17.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
4.1 | 20.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.9 | 15.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
3.7 | 11.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.6 | 14.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.3 | 9.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.3 | 9.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.1 | 9.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.9 | 8.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.9 | 14.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.9 | 17.1 | GO:0048495 | Roundabout binding(GO:0048495) |
2.7 | 8.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.6 | 7.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
2.6 | 28.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.4 | 7.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.4 | 7.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.4 | 7.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.3 | 7.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.3 | 6.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.3 | 9.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.1 | 6.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.1 | 38.4 | GO:0005112 | Notch binding(GO:0005112) |
2.1 | 16.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.1 | 16.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.0 | 6.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.9 | 13.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.9 | 7.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.8 | 7.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 10.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.8 | 8.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.8 | 21.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.7 | 3.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 24.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.7 | 5.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.6 | 12.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.6 | 11.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 9.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.6 | 3.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 6.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.5 | 4.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.5 | 9.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.5 | 7.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.5 | 3.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.5 | 7.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.5 | 5.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 7.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.4 | 4.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.4 | 26.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.3 | 5.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 8.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.3 | 2.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.3 | 11.6 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 10.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.3 | 5.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.3 | 40.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 3.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.2 | 16.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 6.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.2 | 24.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 6.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.2 | 4.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.2 | 3.6 | GO:0018542 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.2 | 5.9 | GO:0045545 | syndecan binding(GO:0045545) |
1.2 | 5.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 3.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.1 | 12.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 11.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 12.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 10.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.1 | 13.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 24.7 | GO:0005272 | sodium channel activity(GO:0005272) |
1.1 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 5.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.1 | 22.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.1 | 5.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 3.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.1 | 7.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.1 | 32.0 | GO:0045296 | cadherin binding(GO:0045296) |
1.1 | 9.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 26.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 8.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 7.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.0 | 3.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.0 | 4.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 7.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 6.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.0 | 6.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.0 | 11.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.9 | 3.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.9 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.9 | 3.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.9 | 6.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.9 | 2.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.9 | 5.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.9 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 27.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.9 | 2.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.9 | 24.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 11.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.9 | 1.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 3.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 5.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 4.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 7.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 0.8 | GO:0070697 | activin receptor binding(GO:0070697) |
0.8 | 4.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.8 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.8 | 10.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.8 | 3.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 2.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 4.0 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 9.5 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 22.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 0.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.8 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 2.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 15.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 2.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 2.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 5.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.7 | 2.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 9.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 2.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 4.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 15.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 10.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.7 | 2.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 3.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 8.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 5.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.7 | 6.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.7 | 19.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 9.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 2.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 2.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 1.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.6 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.7 | 2.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 3.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 1.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 5.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 8.2 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 1.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 2.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 13.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 1.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.6 | 0.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.6 | 24.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 7.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 4.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 0.6 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.6 | 1.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 1.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.6 | 3.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 6.7 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 2.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 6.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 4.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 15.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 3.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 50.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 12.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 2.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 7.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 2.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 4.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.0 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.5 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 3.0 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 8.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 2.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 0.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 4.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 6.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 19.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 1.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 5.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.5 | 5.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 7.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 4.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 7.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 7.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 6.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 8.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 1.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 2.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 5.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 11.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.4 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 3.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 1.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 3.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.4 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 2.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 0.8 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.4 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 13.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 2.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 2.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 3.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 1.2 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 6.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 7.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 2.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 2.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.4 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 3.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 4.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 1.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 1.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 8.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 1.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 2.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 3.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 8.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 5.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 4.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 2.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 2.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 4.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 5.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.2 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 9.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 4.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 6.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 1.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 4.0 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) transmembrane receptor protein phosphatase activity(GO:0019198) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.3 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 2.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 0.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 0.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 2.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 3.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 3.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.2 | 0.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 1.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 13.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 10.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 6.2 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.2 | 2.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 4.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 2.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 6.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 1.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 5.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 8.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.3 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 3.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 3.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 3.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 6.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 2.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 39.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 4.0 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 15.3 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.2 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 3.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 6.0 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.2 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 10.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0034796 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0019152 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 31.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 43.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.9 | 24.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 14.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 17.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 12.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 10.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 3.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 21.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 7.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 13.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 6.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 2.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 25.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 5.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 14.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 8.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 7.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 4.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 5.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 8.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 8.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 55.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 66.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 4.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 12.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 74.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 6.9 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 6.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 5.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 2.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 11.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 17.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 20.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.1 | 32.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.1 | 2.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
2.1 | 25.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.1 | 22.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.8 | 25.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 36.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.5 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.4 | 36.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 2.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.3 | 10.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.3 | 13.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 13.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.3 | 55.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.3 | 17.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.3 | 29.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 9.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 2.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.2 | 14.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.2 | 12.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 1.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.1 | 12.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.1 | 42.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.0 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 7.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 35.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.9 | 3.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 17.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.9 | 7.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.9 | 10.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.9 | 9.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 19.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.8 | 0.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 2.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.7 | 11.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 8.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 45.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.7 | 8.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 6.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 4.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 6.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 22.6 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.6 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 11.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.5 | 86.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 5.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 5.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.4 | 3.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 9.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 5.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 12.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 6.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 5.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 15.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 10.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 3.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 4.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 5.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 3.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 3.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 4.7 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.2 | 4.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 5.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 7.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 3.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 5.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 3.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 1.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 5.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 3.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 2.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |